MKI The Medipattern Corp.

The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI),
a pioneer in the development of medical imaging software solutions that help
medical practitioners to better understand lesions and critical anatomy,
announced today that the Company's new Visualize:Vascular(TM) is now being used
in four states in the US: New Hampshire, New York, New Jersey and Pennsylvania.
The Company is rolling out the product through a controlled launch which began
last June in New York. The product was initially targeted for vascular surgeons
and through the launch phase was opened to interventional cardiologists and
vascular radiologists. In January, the customer base expanded to include general
cardiologists, general radiologists and internists. Visualize:Vascular has now
been deployed in 20 sites as the Company continues to validate its sales model
and refine the strategy before the national launch. 


Medipattern has been attentively monitoring the progress of Visualize:Vascular
as the Company enters the vascular arena, and has utilized customer feedback
from initial sites to make adjustments intended to ensure success in the market.
The Company is now widening its market reach to a larger territory and more
medical professionals. Visualize:Vascular can be used by any practice that
performs carotid duplex exams on patients to identify those at risk of stroke.
As well, the Company has identified other target users such as internists who
provide carotid exams for their patients and then in turn have radiologists
interpret the exams for them. 


Commented Medipattern CEO, Jeff Collins, "Visualize:Vascular is an additional
procedure which is billed on a per-use basis. We are experiencing a longer than
expected lag time between closing the sale and implementing Visualize:Vascular
in the practice. The practices require some time for training, modifying
workflow, informing their referring physicians that they now offer a new
procedure, and implementing the additional Common Procedural Terminology (CPT)
code to enable reimbursement. Revenue on initial quarters will be mainly driven
by initial purchases, while per-use renewal license revenue will contribute to
successive quarters. To date the per-use business model has been confirmed as
customers continue to order license renewals. We expect our revenue to progress
as scan volumes increase while customers integrate Visualize:Vascular into their
workflow throughout the calendar year."




Upcoming Events                                              
                                                             
Annual Hospital - Physician    March 16, 2012 Waltham, MA    
Leadership Conference MHA                                    
                                                             
Annual Meeting - MHA           June 6 - 7, 2012 Brewster, MA 
                                                             
SVU/SVS Annual Conference      June 7 - 9, 2012 Baltimore, MD



About the Medipattern Corporation: 

Medipattern(R) is a pioneer in the development of imaging software solutions
that help medical practitioners to better understand lesions and critical
anatomy. Medipattern uses its Cadenza(TM) technology to process images, finding
the salient region of interest and presenting them in 2D and 3D formats that
enhance the reader's perception. For more information, please visit the
Company's website: www.medipattern.com.


Medipattern(R) is a registered mark of The Medipattern Corporation.
Visualize:Vascular(TM) is a trademark of the Medipattern Corporation.


Forward-looking statements 

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates", "believes", "estimates", "expects", "plans", "intends",
"potential", and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings, (posted at www.sedar.com). In addition, these
forward-looking statements relate to the date on which they are made. The
Company disclaims any intention or obligation to update or revise any
forward-looking statements for any reason. Readers should not rely on
forward-looking statements.

Grafico Azioni The Medipattern Corp. (TSXV:MKI)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni The Medipattern Corp. (TSXV:MKI)
Storico
Da Giu 2023 a Giu 2024